{"DataElement":{"publicId":"2007130","version":"1","preferredName":"Pre Existing Condition","preferredDefinition":"Information about a subject at a specific point in time, and the presence or absence of concomitant/previous illnesses or conditions.","longName":"PRE_EXIST_CONDITION","context":"SPOREs","contextVersion":"2.31","DataElementConcept":{"publicId":"2014740","version":"1","preferredName":"Pre Existing Condition","preferredDefinition":"Name of a person's condition or disease that is preexisting a specific point in time.","longName":"PRE_EXIST_CONDITION","context":"SPOREs","contextVersion":"2.31","ObjectClass":{"publicId":"2444517","version":"1","preferredName":"Condition","preferredDefinition":"A state of being, such as a state of health or physical being.","longName":"C25457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Condition","conceptCode":"C25457","definition":"A state of being, such as a state of health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B4698C3-CEA5-070E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"ONEDATA","dateModified":"2006-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE07B105-9257-2B65-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018924","version":"1","preferredName":"Condition Name","preferredDefinition":"Text names to represent a person's disease or condition.","longName":"COND_NM","context":"SPOREs","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pneumonia","valueDescription":"Pneumonia","ValueMeaning":{"publicId":"2559821","version":"1","preferredName":"Pneumonia","longName":"2559821","preferredDefinition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6BA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2020-11-19","changeDescription":"11.19.2020 Updated concept annotation and long name to current NCIt . mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40A6-2ACD-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Acute Bronchitis","valueDescription":"Acute Bronchitis","ValueMeaning":{"publicId":"2565938","version":"1","preferredName":"Acute Bronchitis","longName":"2565938v1.00","preferredDefinition":"Acute inflammation and edema of the larger bronchi caused by viruses or bacteria.  Signs and symptoms include cough, sputum production, shortness of breath, and wheezing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Bronchitis","conceptCode":"C26932","definition":"Acute inflammation and edema of the larger bronchi caused by viruses or bacteria.  Signs and symptoms include cough, sputum production, shortness of breath, and wheezing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE9F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40A9-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Bleeding Diathesis","valueDescription":"Bleeding Tendency","ValueMeaning":{"publicId":"2565939","version":"1","preferredName":"Bleeding Tendency","longName":"2565939v1.00","preferredDefinition":"A coagulation disorder characterized by a tendency for excessive bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bleeding Diathesis","conceptCode":"C115221","definition":"A coagulation disorder characterized by a tendency for excessive bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40AC-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Coronary Artery Disease, MI","valueDescription":"Coronary artery disorders","ValueMeaning":{"publicId":"2565940","version":"1","preferredName":"Coronary artery disorders","longName":"2565940","preferredDefinition":"coronary arteriosclerosis. degenerative and metabolic changes of the walls of the coronary arteries usually beginning with atheroma of the intima and preceding to involve the media; also, calcified lesions known as Monckeberg's arteriosclerosis; C0010054: Coronary artery disorders","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary artery disorders","conceptCode":"C0010054","definition":"Thickening and loss of elasticity of the coronary arteries, leading to progressive insufficiency of the arteries (CORONARY DISEASE).","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40AF-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hypoxemia or Prescribed Home Oxygen","valueDescription":"Hypoxemia","ValueMeaning":{"publicId":"2565941","version":"1","preferredName":"Hypoxemia","longName":"2565941v1.00","preferredDefinition":"A finding indicating decreased oxygen levels in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypoxemia","conceptCode":"C93047","definition":"A finding indicating decreased oxygen levels in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"KUMMEROA","dateModified":"2023-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40B2-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Cardiac Dysrythmia","valueDescription":"CARDIOVASCULAR (ARRHYTHMIA)","ValueMeaning":{"publicId":"2561527","version":"1","preferredName":"CARDIOVASCULAR (ARRHYTHMIA)","longName":"2561527v1.00","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BD64-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-05","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-05","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40B5-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Bronchopulmonary Disorders","valueDescription":"Bronchopulmonary Disorders","ValueMeaning":{"publicId":"2565942","version":"1","preferredName":"Bronchopulmonary Disorders","longName":"2565942","preferredDefinition":"CL050695: Respiratory tract disorders NEC\r\n","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"MEDVEDOH","dateModified":"2003-05-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40B8-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Chest Pain","valueDescription":"Chest pain","ValueMeaning":{"publicId":"2562664","version":"1","preferredName":"Chest pain","longName":"2562664v1.00","preferredDefinition":"Pain in the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chest Pain","conceptCode":"C38665","definition":"Pain in the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40BE-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Congestive Heart Failure","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40C1-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"DIABETES","ValueMeaning":{"publicId":"2558616","version":"1","preferredName":"DIABETES","longName":"2558616v1.00","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B205-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40C4-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE0B306A-AE16-399B-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Weight Loss","valueDescription":"Weight decreased","ValueMeaning":{"publicId":"2562713","version":"1","preferredName":"Weight decreased","longName":"2562713v1.00","preferredDefinition":"A reduction in total body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Loss","conceptCode":"C3445","definition":"A reduction in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C206-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE0B306A-AE19-399B-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Hepatobiliary Disorders","valueDescription":"Hepatobiliary Disorders","ValueMeaning":{"publicId":"2565943","version":"1","preferredName":"Hepatobiliary Disorders","longName":"2565943v1.00","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatobiliary Disorder","conceptCode":"C3959","definition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE07E27F-40BB-2ACD-E034-0003BA12F5E7","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Diverticulitis","valueDescription":"Diverticulitis","ValueMeaning":{"publicId":"2577629","version":"1","preferredName":"Diverticulitis","longName":"2577629","preferredDefinition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diverticulitis","conceptCode":"C26752","definition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C236CBF-D05F-2FB2-E044-0003BA3F9857","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"REEVESD","dateModified":"2006-02-08","deletedIndicator":"No"},{"value":"Diverticulosis","valueDescription":"Diverticulosis","ValueMeaning":{"publicId":"2577630","version":"1","preferredName":"Diverticulosis","longName":"2577630","preferredDefinition":"A condition marked by small sacs or pouches (diverticula) in the walls of an organ such as the stomach or colon. These sacs can become inflamed and cause a condition called diverticulitis, which may be a risk factor for certain types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diverticulosis","conceptCode":"C4922","definition":"A finding indicating the presence of multiple pouches, usually in the colonic or gastric wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC4B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"ONEDATA","dateModified":"2006-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C236CBF-D060-2FB2-E044-0003BA3F9857","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"REEVESD","dateModified":"2006-02-08","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":"Hypertension","ValueMeaning":{"publicId":"2558888","version":"1","preferredName":"Hypertension","longName":"2558888","preferredDefinition":"Pathological increase in blood pressure; a repeatedly elevated blood pressure exceeding 140 over 90 mmHg.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B315-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE89-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Stroke","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"2569507","version":"1","preferredName":"Cerebrovascular Accident","longName":"2569507","preferredDefinition":"A sudden, nonconvulsive loss of neurologic function due to an ischemic or hemorrhagic intracranial vascular event. In general, cerebrovascular accidents are classified by anatomic location in the brain, vascular distribution, etiology, age of the affected individual, and hemorrhagic vs. nonhemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC90-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"CZECHS","dateModified":"2008-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE8D-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Emphysema","valueDescription":"Pulmonary Emphysema","ValueMeaning":{"publicId":"2558715","version":"1","preferredName":"Pulmonary Emphysema","longName":"2558715","preferredDefinition":"A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Emphysema","conceptCode":"C3348","definition":"A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B268-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE8E-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Chronic Bronchitis","valueDescription":"Chronic Bronchitis","ValueMeaning":{"publicId":"2570180","version":"1","preferredName":"Chronic Bronchitis","longName":"2570180","preferredDefinition":"condition characterized by persistent coughing, increased secretion from the bronchial mucosa, obstruction of the respiratory passages, scanty or profuse expectoration, and necrosis and fibrosis of the respiratory tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Bronchitis","conceptCode":"C26722","definition":"A type of chronic obstructive pulmonary disease characterized by chronic inflammation in the bronchial tree that results in edema, mucus production, obstruction, and reduced airflow to and from the lung alveoli.  The most common cause is tobacco smoking.  Signs and symptoms include coughing with excessive mucus production, and shortness of breath.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF31-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE92-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Colorectal polyp(s)","valueDescription":"Colorectal Polyp","ValueMeaning":{"publicId":"2577523","version":"1","preferredName":"Colorectal Polyp","longName":"2577523v1.00","preferredDefinition":"A polypoid lesion that arises from the colon or rectum and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Polyp","conceptCode":"C5679","definition":"A polypoid lesion that arises from the colon or rectum and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE93-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Ulcerative colitis","valueDescription":"Ulcerative Colitis","ValueMeaning":{"publicId":"2577524","version":"1","preferredName":"Ulcerative Colitis","longName":"2577524","preferredDefinition":"Inflammatory disease of unknown cause which involves the mucosa of the colon. Onset may be acute and fulminant, and its course often continues chronically in an intermittent or continuous form. Diarrhea is a common symptom and bleeding an almost constant concomitant symptom.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulcerative Colitis","conceptCode":"C2952","definition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"CZECHS","dateModified":"2008-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE94-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Crohn's Disease","valueDescription":"Crohn Disease","ValueMeaning":{"publicId":"2577525","version":"1","preferredName":"Crohn Disease","longName":"2577525","preferredDefinition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn's disease most commonly involves the terminal ileum; the colon is the second most common site of involvement. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crohn Disease","conceptCode":"C2965","definition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE95-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Familial polyposis","valueDescription":"Adenomatous Polyposis Coli","ValueMeaning":{"publicId":"2577526","version":"1","preferredName":"Adenomatous Polyposis Coli","longName":"2577526","preferredDefinition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Familial Adenomatous Polyposis","conceptCode":"C3339","definition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE96-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":"Osteoporosis","ValueMeaning":{"publicId":"2563635","version":"1","preferredName":"Osteoporosis","longName":"2563635","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-05","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-12-05","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE97-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Gardner's Syndrome","valueDescription":"Gardner's Syndrome","ValueMeaning":{"publicId":"2577527","version":"1","preferredName":"Gardner's Syndrome","longName":"2577527","preferredDefinition":"An autosomal dominant syndrome characterised by multiple colonic polyps predisposing to carcinoma of the colon, osteomas of the skull, epidermoid cysts, and fibromas.  It is associated with mutation of the APC gene. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gardner Syndrome","conceptCode":"C6728","definition":"A variant of familial adenomatous polyposis. It is an autosomal dominant syndrome characterized by multiple colonic polyps predisposing to carcinoma of the colon, osteomas of the skull, epidermoid cysts, and fibromas. It is associated with mutation of the APC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"ONEDATA","dateModified":"2006-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CE98-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"2567490","version":"1","preferredName":"Hepatitis","longName":"2567490","preferredDefinition":"Inflammation of the liver and liver disease involving degenerative or necrotic alterations of hepatocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4AF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CEA0-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"2558505","version":"1","preferredName":"Cirrhosis","longName":"2558505","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholisms, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B196-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CEA1-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Gallbladder stone(s) or inflammation","valueDescription":"Gallbladder Stone","ValueMeaning":{"publicId":"2577528","version":"1","preferredName":"Gallbladder Stone","longName":"2577528v1.00","preferredDefinition":"Single or multiple, ovoid or irregular, solid particles that are formed from bile, cholesterol, and calcium in the gallbladder cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Stone","conceptCode":"C34443","definition":"Single or multiple, ovoid or irregular, solid particles that are formed from bile, cholesterol, and calcium in the gallbladder cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4698C3-CEA2-070E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"REEVESD","dateModified":"2006-01-28","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":"Arthritis","ValueMeaning":{"publicId":"2569498","version":"1","preferredName":"Arthritis","longName":"2569498","preferredDefinition":"Inflammation of a joint or a state characterized by inflammation of joints.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC87-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B73FFF7-D7CB-535E-E044-0003BA3F9857","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"ONEDATA","dateModified":"2006-01-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008571","version":"1","preferredName":"Chronic or Associated Diseases and Exposures","preferredDefinition":"chronic diseases, as well as diseases and exposures associated with cancer.","longName":"CHR_O_ASS_DZ_AND_EXP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9B9249B-AB81-2F8D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-25","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE07B829-71BA-2ADB-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"COOPERM","dateModified":"2020-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2180156","version":"1","longName":"New CDEs per study","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2811713","version":"1","longName":"Iloprost 01279","context":"SPOREs"}]},{"publicId":"2718902","version":"1","longName":"ONS (Oncology Nursing Society)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812728","version":"1","longName":"Multisite Research Study","context":"NCIP"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Have you ever been told by a","type":"Preferred Question Text","description":"Have you ever been told by a doctor that you have/ had any of the following conditions or dieseases?","url":null,"context":"SPOREs"},{"name":"CRF TEXT","type":"Alternate Question Text","description":"Pre Existing Condition","url":null,"context":"SPOREs"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BE07B829-71BB-2ADB-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"DWARZEL","dateModified":"2011-08-17","changeDescription":"Possible CDEs for Hepatitis B Position Statement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}